Vermont

The Department of Vermont Health Access recently released its March 2022 Pharmacy Newsletter. It contains information on: 

• Pharmacy Benefit Provider Satisfaction Survey 
• Hypertension Management Initiative  
• Team Care Program 
• Important Changes to Administration Fees for Vaccines  
• Update on Pharmacy COVID-19 Antigen Test Coverage  
• Preferred Drug List (PDL) 
• New DURB Board Member 
• Drug Utilization Review Board (DURB) Meeting 
• Website Updates 

Also in Vermont, the Department of Vermont Health Access issued a communication that Synagis® prophylaxis is of unproven value when administered outside of the RSV season as defined by the CDC surveillance reports. Therefore, no further shipments will be authorized after March 11. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.